Crossmark

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

Crossref DOI link: https://doi.org/10.1038/bcj.2016.93

Published Online: 2016-11-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Paulus, A

Akhtar, S

Caulfield, T R

Samuel, K

Yousaf, H

Bashir, Y

Paulus, S M

Tran, D

Hudec, R

Cogen, D

Jiang, J

Edenfield, B

Novak, A

Ansell, S M

Witzig, T

Martin, P

Coleman, M

Roy, V

Ailawadhi, S

Chitta, K

Linder, S

Chanan-Khan, A
License Information

Text and Data Mining valid from 2016-11-04

Version of Record valid from 2016-11-04
More Information

Article History

Received: 6 May 2016

Revised: 21 July 2016

Accepted: 22 August 2016

First Online: 4 November 2016

Competing interests

: The authors declare no conflict of interest, except for Dr Linder who is a shareholder in Vivolux AB.

Document is current

Any future updates will be listed below